The invention relates to a process for preparing unipolar cation-conducting ionomers from fluoro ionic monomers, to said unipolar cation-conducting ionomers, to the uses thereof, to an electrolytic composition comprising at least one of said unipolar cation-conducting ionomers and to an electrochemical device comprising at least one of said unipolar cation-conducting ionomers, especially as electrolyte.

A compound represented by formula (I) or a salt thereof. ##STR00001## In formula (I), R.sup.1 and R.sup.4 each independently represent a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group or the like. R.sup.2 represents a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group or the like. R.sup.3 represents an unsubstituted or substituted C1 to C6 alkyl group or the like. R.sup.5 represents a C1 to C6 haloalkyl group or the like. G represents an oxygen atom or a sulfur atom. R.sup.6 and R.sup.7 each independently represent a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group or the like. n represents 0 or 1. R.sup.8 and R.sup.9 each independently represent a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group. Ar represents an unsubstituted or substituted C6 to C10 aryl group or the like.

A compound represented by formula (I) or a salt thereof. ##STR00001## In formula (I), R.sup.1 and R.sup.4 each independently represent a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group or the like. R.sup.2 represents a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group or the like. R.sup.3 represents an unsubstituted or substituted C1 to C6 alkyl group or the like. R.sup.5 represents a C1 to C6 haloalkyl group or the like. G represents an oxygen atom or a sulfur atom. R.sup.6 and R.sup.7 each independently represent a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group or the like. n represents 0 or 1. R.sup.8 and R.sup.9 each independently represent a hydrogen atom, or an unsubstituted or substituted C1 to C6 alkyl group. Ar represents an unsubstituted or substituted C6 to C10 aryl group or the like.

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula:

##STR00001##

wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula:

##STR00001##

wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.

A resist composition comprising a base polymer and a quencher containing a sulfonium salt having an iodized benzene ring offers a high sensitivity, minimal LWR and improved CDU independent of whether it is of positive or negative tone.

A resist composition comprising a base polymer and a quencher containing a sulfonium salt having an iodized benzene ring offers a high sensitivity, minimal LWR and improved CDU independent of whether it is of positive or negative tone.

Described are compounds of the formula: wherein R.sup.Aryl is an aryl group; R.sup.1 is a linear or branched C.sub.2-C.sub.40 hydrocarbyl group; R.sup.2 is a C.sub.1-C.sub.4 alkyl; R.sub.f is a perfluorinated group of having an average of 3 to 5 carbon atoms; and subscript x is 1 to 3.
R.sup.ArylCO.sub.2R.sup.1NR.sup.2SO.sub.2R.sub.f].sub.x

Described are compounds of the formula: wherein R.sup.Aryl is an aryl group; R.sup.1 is a linear or branched C.sub.2-C.sub.40 hydrocarbyl group; R.sup.2 is a C.sub.1-C.sub.4 alkyl; R.sub.f is a perfluorinated group of having an average of 3 to 5 carbon atoms; and subscript x is 1 to 3.
R.sup.ArylCO.sub.2R.sup.1NR.sup.2SO.sub.2R.sub.f].sub.x

This invention provides, but is not limited to, novel oleanolic acid derivatives having the formula: ##STR00001##
wherein the variables are defined herein. Also provided are pharmaceutical compositions, kits and articles of manufacture comprising such compounds, methods and intermediates useful for making the compounds, and methods of using the compounds and compositions.